Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES - International Association of Libraries and Museums of the Performing Arts - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-06-02 15:25:44 Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Amides Anti-diabetic drugs Peptide hormones Exenatide Anti-diabetic medication Sitagliptin Saxagliptin Metformin Glucagon-like peptide-1 agonist Sulfonylurea		Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES Add to Reading List Source URL: poisoncontrol.utah.edu Download Document from Source Website File Size: 1,00 MB Share Document on Facebook

	Texas Business Group on HealthTEXAS TYPE DocID: 1qBzC - View Document
	Asian Pacific Journal of Tropical DiseaseContents lists available at ScienceDirect Asian Pacific Journal of Tropical Disease journal homepage:www.elsevier.com/locate/apjtd DocID: 1qBbb - View Document
	actos vs januvia. actos 1.2 mg. actos 30 mg side effects glimeperide with actos and januvia. what is ursus actos, actos goes generic. actos corporation januvia vs actos lawyer for actos lawsuitque son los actos pr DocID: 1qAuT - View Document
	Zuercher_HealthLiteracy_2014_VFinal DocID: 1qrty - View Document
	Peytremann-Bridevaux et al. BMC Health Services Research 2013, 13:232 http://www.biomedcentral.com RESEARCH ARTICLE Open Access DocID: 1qj8G - View Document